Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

1.140 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 0
Open 1.140
Bid (Size) 1.120 (100)
Ask (Size) 1.180 (200)
Prev. Close 1.140
Today's Range 1.140 - 1.140
52wk Range 1.040 - 2.680
Shares Outstanding 140,759,276
Dividend Yield N/A

Performance

YTD
-28.8%
-28.8%
1 Month
-14.9%
-14.9%
3 Month
-37.0%
-37.0%
6 Month
-52.9%
-52.9%
1 Year
-36.0%
-36.0%

More News

Read More

Frequently Asked Questions

Is Heron Therapeutics, Inc. - Common Stock publicly traded?
Yes, Heron Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Heron Therapeutics, Inc. - Common Stock trade on?
Heron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heron Therapeutics, Inc. - Common Stock?
The ticker symbol for Heron Therapeutics, Inc. - Common Stock is HRTX on the Nasdaq Stock Market
What is the current price of Heron Therapeutics, Inc. - Common Stock?
The current price of Heron Therapeutics, Inc. - Common Stock is 1.140
When was Heron Therapeutics, Inc. - Common Stock last traded?
The last trade of Heron Therapeutics, Inc. - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of Heron Therapeutics, Inc. - Common Stock?
The market capitalization of Heron Therapeutics, Inc. - Common Stock is 160.47M
How many shares of Heron Therapeutics, Inc. - Common Stock are outstanding?
Heron Therapeutics, Inc. - Common Stock has 160M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.